Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by Korea government (MIST) (No. 2020R1A2C1005345).
References
- Page MA, Mathers WD. Acanthamoeba keratitis: a 12-year experience covering a wide spectrum of presentations, diagnoses, and outcomes. J Ophthalmol 2013; 2013: 670242. https://doi.org/10.1155/2013/670242
- Singh A, Sahu SK, Sharma S, Das S. Acanthamoeba keratitis versus mixed Acanthamoeba and bacterial keratitis: comparison of clinical and microbiological profiles. Cornea 2020; 39: 1112-1116. https://doi.org/10.1097/ICO.0000000000002337
- Raghavan A, Baidwal S, Venkatapathy N, Rammohan R. The Acanthamoeba-fungal keratitis study. Am J Ophthalmol 2019; 201: 31-36 https://doi.org/10.1016/j.ajo.2019.01.024
- Fanselow N, Sirajuddin N, Yin XT, Huang AJW, Stuart PM. Acanthamoeba keratitis, pathology, diagnosis and treatment. Pathogens 2021; 10: 323. https://doi.org/10.3390/pathogens10030323
- Szentmary N, Daas L, Shi L, Laurik KL, Lepper S, Milioti G, Seitz B. Acanthamoeba keratitis-Clinical signs, differential diagnosis and treatment. J Curr Ophthalmol 2018; 31: 16-23. https://doi.org/10.1016/j.joco.2018.09.008
- Sharma S, Athmanathan S, Ata-Ur-Rasheed M, Garg P, Rao GN. Evaluation of immunoperoxidase staining technique in the diagnosis of Acanthamoeba keratitis. Indian J Ophthalmol 2001; 49: 181-186.
- Turner ML, Cockerell EJ, Brereton HM, Badenoch PR, Tea M, Coster DJ, Williams KA. Antigens of selected Acanthamoeba species detected with monoclonal antibodies. Int J Parasitol 2005; 35: 981-990. https://doi.org/10.1016/j.ijpara.2005.03.015
- Weber-Lima MM, Prado-Costa B, Becker-Finco A, Costa AO, Billilad P, Furst C, de Moura JF, Alvarenga LM. Acanthamoeba spp. monoclonal antibody against a CPA2 transporter: a promising molecular tool for acanthamoebiasis diagnosis and encystment study. Parasitology 2020; 147: 1678-1688. https://doi.org/10.1017/S0031182020001778
- Kang AY, Park AY, Shin HJ, Khan NA, Maciver SK, Jung SY. Production of a monoclonal antibody against a mannose-binding protein of Acanthamoeba culbertsoni and its localization. Exp Parasitol 2018; 192: 19-24. https://doi.org/10.1016/j.exppara.2018.07.009
- Park SM, Lee HA, Chu KB, Quan FS, Kim SJ, Moon EK. Production of a polyclonal antibody against inosine-uridine preferring nucleoside hydrolase of Acanthamoeba castellanii and its access to diagnosis of Acanthamoeba keratitis. PLoS One 2020; 15: e0239867 https://doi.org/10.1371/journal.pone.0239867
- Lee HA, Chu KB, Kim MJ, Quan FS, Kong HH, Moon EK. Chorismate mutase peptide antibody enables specific detection of Acanthamoeba. PLoS One 2021; 16: e0250342. https://doi.org/10.1371/journal.pone.0250342
- Field J, Nikawa J, Broek D, MacDonald B, Rodgers L, Wilson IA, Lerner RA, Wigler M. Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol 1988; 8: 2159-2165. https://doi.org/10.1128/mcb.8.5.2159-2165.1988
- Noegel AA, Rivero F, Albrecht R, Janssen KP, Kohler J, Parent CA, Schleicher M. Assessing the role of the ASP56/CAP homologue of Dictyostelium discoideum and the requirements for subcellular localization. J Cell Sci 1999; 112: 3195-3203. https://doi.org/10.1242/jcs.112.19.3195
- Kakurina GV, Kolegova ES, Kondakova IV. Adenylyl cyclase-associated protein 1: structure, regulation, and participation in cellular processes. Biochemistry (Mosc) 2018; 83: 45-53. https://doi.org/10.1134/S0006297918010066
- Hubberstey AV, Mottillo EP. Cyclase-associated proteins: CAPacity for linking signal transduction and actin polymerization. FASEB J 2002; 16: 487-499. https://doi.org/10.1096/fj.01-0659rev
- Zhang H, Ghai P, Wu H, Wang C, Field J, Zhou GL. Mammalian adenylyl cyclase-associated protein 1 (CAP1) regulates cofilin function, the actin cytoskeleton, and cell adhesion. J Biol Chem 2013; 288: 20966-20977. https://doi.org/10.1074/jbc.M113.484535
- Li L, Fu LQ, Wang HJ, Wang YY. CAP2 is a valuable biomarker for diagnosis and prognostic in patients with gastric cancer. Pathol Oncol Res 2020; 26: 273-279. https://doi.org/10.1007/s12253-018-0450-4
- Xu L, Peng S, Huang Q, Liu Y, Jiang H, Li X, Wang J. Expression status of cyclase-associated protein 2 as a prognostic marker for human breast cancer. Oncol Rep 2016; 36: 1981-1988. https://doi.org/10.3892/or.2016.5051
- Fu J, Li M, Wu DC, Liu LL, Chen SL, Yun JP. Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma. Transl Oncol 2015; 8: 400-406. https://doi.org/10.1016/j.tranon.2015.08.003
- Moon EK, Choi HS, Park SM, Kong HH, Quan FS. Comparison of proteins secreted into extracellular space of pathogenic and non-pathogenic Acanthamoeba castellanii. Korean J Parasitol 2018; 56: 553-558. https://doi.org/10.3347/kjp.2018.56.6.553
- Clarke DW, Niederkorn JY. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol 2006; 22: 175-180. https://doi.org/10.1016/j.pt.2006.02.004
- Maycock NJ, Jayaswal R. Update on Acanthamoeba keratitis: diagnosis, treatment, and outcomes. Cornea 2016; 35: 713-720. https://doi.org/10.1097/ICO.0000000000000804
- Sharma S, Garg P, Rao GN. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 2000; 84: 1103-1108. https://doi.org/10.1136/bjo.84.10.1103
- Alizadeh H, Apte S, El-Agha MS, Li L, Hurt M, Howard K, Cavanagh HD, McCulley JP, Niederkorn JY. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea 2001; 20: 622-627. https://doi.org/10.1097/00003226-200108000-00013
- Walochnik J, Obwaller A, Haller-Schober EM, Aspock H. Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities in correlation to strain pathogenicity. Parasitol Res 2001; 87: 651-656. https://doi.org/10.1007/s004360100412
- Alvarez-Curto E, Saran S, Meima M, Zobel J, Scott C, Schaap P. cAMP production by adenylyl cyclase G induces prespore differentiation in Dictyostelium slugs. Development 2007; 134: 959-66. https://doi.org/10.1242/dev.02775